Advanced search
Publication Cover
Current Medical Research and Opinion Volume 38, 2022 - Issue 1
Submit an article Journal homepage
455
Views
5
CrossRef citations to date
0
Altmetric
Pediatrics

IgA nephropathy in a child: Crohn’s disease-associated or adalimumab induced?

Francesco Grazianoa Pediatric Unit, Villa Sofia Cervello Hospital, Palermo, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4896-1842
ORCID Icon,
Martina Busèb UOSD Medical Genetics, Villa Sofia Cervello Hospital, Palermo, Italy
,
Nicola Cassataa Pediatric Unit, Villa Sofia Cervello Hospital, Palermo, Italy
,
Vincenzo Luca Lentinic UOC of Pathology, Villa Sofia Cervello Hospital, Palermo, Italy
&
Michele Citranoa Pediatric Unit, Villa Sofia Cervello Hospital, Palermo, Italy
Pages 139-143 | Received 25 May 2021, Accepted 30 Nov 2021, Published online: 13 Dec 2021

References

  • Corica D, Romano C. Renal involvement in inflammatory bowel diseases. J Crohns Colitis. 2016;10(2):226–235.
  • Mutalib M. Renal involvement in paediatric inflammatory bowel disease. Pediatr Nephrol. 2021;36(2):279–285.
  • Filiopoulos V, Trompouki S, Hadjiyannakos D, et al. IgA nephropathy in association with Crohn’s disease: a case report and brief review of the literature. Ren Fail. 2010;32(4):523–527.
  • Forshaw MJ, Guirguis O, Hennigan TW. IgA nephropathy in association with Crohn’s disease. Int J Colorectal Dis. 2005;20(5):463–465.
  • Lee JM, Lee KM, Kim HW, Chung WC, et al. Crohn’s disease in association with IgA nephropathy. Korean J Gastroenterol. 2008;52(2):115–119.
  • Youm JY, Lee OY, Park MH, et al. [Crohn’s disease associated with IgA nephropathy]. Korean J Gastroenterol. 2006;47(4):324–328.
  • Choi JY, Yu CH, Jung HY, Jung MK, et al. A case of rapidly progressive IgA nephropathy in a patient with exacerbation of Crohn’s disease. BMC Nephrol. 2012;13:84.
  • Terasaka T, Uchida HA, Umebayashi R, et al. The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn’s disease. BMC Nephrol. 2016; 17(1):122.
  • Shaer AJ, Stewart LR, Cheek DE, et al. IgA antiglomerular basement membrane nephritis associated with Crohn’s disease: a case report and review of glomerulonephritis in inflammatory bowel disease. Am J Kidney Dis. 2003;41(5):1097–1109.
  • Ambruzs JM, Walker PD, Larsen CP. The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease. CJASN. 2014;9(2):265–270.
  • Pouria S, Barratt J. Secondary IgA nephropathy. Semin Nephrol. 2008;28(1):27–37.
  • Takemura T, Okada M, Yagi K, et al. An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications. Pediatr Nephrol. 2002;17(10):863–866.
  • McCallum D, Smith L, Harley F, et al. IgA nephropathy and thin basement membrane disease in association with crohn disease. Pediatr Nephrol. 1997;11(5):637–640.
  • Den Broeder AA, Assmann KJ, van Riel PL, Wetzels JF. Nephrotic syndrome as a complication of anti-TNFalpha in a patient with rheumatoid arthritis. Neth J Med. 2003;61(4):137–141.
  • Stokes MB, Foster K, Markowitz GS, et al. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant. 2005;20(7):1400–1406.
  • Li X, Ma J, Zhao Y, Wang HY, et al. Development of crescentic immunoglobulin a nephritis and multiple autoantibodies in a patient during adalimumab treatment for rheumatoid arthritis. Chin Med J (Engl). 2015;128(18):2555–2556.
  • Wei SS, Sinniah R. Adalimumab (TNF α inhibitor) therapy exacerbates IgA glomerulonephritis acute renal injury and induces lupus autoantibodies in a psoriasis patient. Case Rep Nephrol. 2013;2013:812781.
  • Premužić V, Padjen I, Cerovec M, et al. The association of TNF-Alpha inhibitors and development of IgA nephropathy in patients with rheumatoid arthritis and diabetes. Case Rep Nephrol. 2020;2020:9480860. Erratum in: Case Rep Nephrol. 2020 Aug 29;2020:7293470
  • Guillevin L, Mouthon L. Tumor necrosis factor-alpha blockade and the risk of vasculitis. J Rheumatol. 2004;31(10):1885–1887.
  • Atzeni F, Turiel M, Capsoni F, et al. Autoimmunity and anti-TNF-alpha agents. Ann N Y Acad Sci. 2005;1051:559–569.
  • Almoallim H, Al-Ghamdi Y, Almaghrabi H, et al. Anti-tumor necrosis factor-α induced systemic lupus erythematosus. Open Rheumatol J. 2012;6:315–319.
  • Ziolkowska M, Maslinski W. Laboratory changes on anti-tumor necrosis factor treatment in rheumatoid arthritis. Curr Opin Rheumatol. 2003;15(3):267–273.
  • Di Lernia V. IgA nephropathy during treatment with TNF-alpha blockers: could it be predicted? Med Hypotheses. 2017;107:12–13. Epub 2017 Jul 16.
  • Strobel T, Ahmed W, De la Sancha C, et al. IgA nephropathy in the setting of anti-TNF-α therapy for inflammatory bowel Disease. ACG Case Rep J. 2020;7(9):e00462.
  • Bhagat Singh AK, Jeyaruban AS, Wilson GJ, et al. Adalimumab-induced IgA nephropathy. BMJ Case Rep. 2019;12(3):e226442.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.